(R)-ACX is a novel sufonylurea compound with potent, quick and short-lasting hypoglycemic activity

Symptomatic Hypoglycemia in NIDDM Patients Treated With Oral Hypoglycemic Agents

Adrian Jennings, R Malcolm Wilson, John D. Ward · Diabetes Care · 1989 · 194 citations

Medicine, Endocrinology, Internal Medicine +14

Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (−)‐N‐(trans‐4‐isopropylcyclohexane‐carbonyl)‐<scp>d</scp>‐phenylalanine (A‐4166)

Takao Ikenoue, Megumi Akiyoshi, Shoji Fujitani et al. · British Journal of Pharmacology · 1997 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.

Hideki Ohnota, Takashi Koizumi, Naoyuki Tsutsumi et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 62 citations

Medicine, Medicinal Chemistry, Pharmacology +9

THE NATURE OF THE METABOLITES OF ACETOHEXAMIDE IN THE RAT AND IN THE HUMAN

Robert E. McMahon, Frederick J. Marshall, Hilman W. Culp · Journal of Pharmacology and Experimental Therapeutics · 1965 · 62 citations

Medicine, Biochemistry, Pharmacology +6

High-Performance Liquid Chromatographic Determination of Acetohexamide and Its Metabolite, Hydroxyhexamide

Yasushi Takagishi, Koji Sato, K. Tomita et al. · YAKUGAKU ZASSHI · 1979 · 21 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17